-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
The company has once again been awarded the title of “Top 100 Globalized Pharmaceutical Enterprises.”
Category:
Time：2019-07-15
From June 18 to 20, the 19th China International Pharmaceutical Ingredients Exhibition (CPhIChina) kicked off with great fanfare at the Shanghai New International Expo Center. On the eve of the exhibition, the winners of the 2019 Top 100 Globalized Pharmaceutical Companies were announced. Shijiazhuang No.4 Pharmaceutical Co., Ltd. once again made the list and was awarded the title of “Leading Enterprise in Formulation Globalization (Top 20).” This highlights the strong international recognition of Shijiazhuang No.4 Pharmaceutical’s products and underscores yet again the company’s internationalization strategy, which has been officially endorsed by a reputable authority.
From June 18 to 20, the 19th China International Pharmaceutical Ingredients Exhibition (CPhI China) kicked off with great fanfare at the Shanghai New International Expo Center. On the eve of the exhibition, the winners of the 2019 Top 100 Globalized Pharmaceutical Companies were announced. Shijiazhuang Fourth Pharmaceutical Co., Ltd. once again made the list and was awarded the title of “Leading Enterprise in Formulation Globalization (Top 20).” This highlights the strong international recognition of Shijiazhuang Fourth Pharmaceutical’s products and underscores yet again the company’s internationalization strategy, which has been officially endorsed by a reputable authority.
The list of “Top 100 Chinese Pharmaceutical Companies Going Global” was unveiled at the “4th Selection of Top 100 Chinese Pharmaceutical Companies Going Global,” an event hosted by the China Chamber of Commerce for Import and Export of Medicines & Health Products. It is understood that the “Selection of Top 100 Chinese Pharmaceutical Companies Going Global” is the most authoritative and influential selection activity in the field of pharmaceutical globalization. The event aims to promote and showcase China’s leading enterprises in pharmaceutical globalization and their “going global” strategies to international markets, encourage innovation in internationalization, enhance the global recognition and influence of China’s leading pharmaceutical companies in this field, and set industry benchmarks for China’s pharmaceutical globalization strategy.
In recent years, as the Ministry of Foreign Trade has continued to explore international markets, enterprises’ capabilities in international operations have significantly strengthened. Last year, we developed 37 new international clients and completed five international quality audits and certifications in countries including the Netherlands and Pakistan. We have now accumulated product registrations in 83 countries, with a total of 131 registered specifications and varieties. Export volumes have been increasing year after year, making this a new highlight in our company’s innovative business strategy.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license